Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 1, 1990
Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridineW S Saari, J E Schwering, P A Lyle, et al.Journal of Medicinal Chemistry|January 1, 1990
Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisoleW S Saari, J E Schwering, P A Lyle, et al.Journal of Medicinal Chemistry|October 1, 1991
Synthesis and evaluation of some nitrobenzenesulfonamides containing nitroisopropyl and (ureidooxy)methyl groups as novel hypoxic cell selective cytotoxic agentsW S Saari, J E Schwering, P A Lyle, et al.Bioorganic & Medicinal Chemistry|May 1, 2007
Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell linesBin Li, Michael P A Lyle, Genhui Chen, et al.American Heart Journal|September 1, 1994
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril InvestigatorsR M Lang, R DiBianco, G T Broderick, et al.Journal of Human Hypertension|May 4, 2007
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE studyG de Simone, M H Olsen, K Wachtell, et al.Current Medical Research and Opinion|March 11, 2008
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertensionS Oparil, N Abate, E Chen, et al.Journal of Medicinal Chemistry|April 1, 1987
Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitorsG S Ponticello, M B Freedman, C N Habecker, et al.Journal of Internal Medicine|September 19, 2007
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE studyE Fossum, G W Gleim, S E Kjeldsen, et al.Journal of Medicinal Chemistry|June 1, 1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2J J Baldwin, M E Christy, G H Denny, et al.Pageof 3